Latest Contracts News

Dotz Nano has achieved a key production milestone for its proprietary CO2 sorbent materials and raised over AU$3 million to accelerate commercialization of its DotzEarth technology.

RocketBoots Limited has secured a transformative $9.1 million annual contract with a major multinational retailer, alongside a $7 million capital raise to accelerate its international growth strategy.

Zoono Group has landed its first commercial orders from three new packaging partners, marking a key milestone in its fresh food shelf-life extension strategy. The company reports NZ$551,000 cash on hand as it navigates growth and funding options.

Etherstack has reported a record-breaking 70% revenue increase in FY25, driven by major contracts and strong cashflow, and is poised for further robust growth in FY26.

Novatti Group has reported its December quarter results, marking a fourth consecutive EBITDA positive quarter in its Payments AU/NZ business and securing $1 million in strategic growth funding. The company’s stake in AUDC has nearly doubled following a successful Pre-Series A funding round.

Mach7 Technologies reports a positive operating cash flow in Q2 FY26, securing its first customer for the new Flamingo Architecture product and advancing key strategic initiatives.

Enlitic, Inc. reported its strongest quarter yet with record contract wins totalling A$4.3 million, alongside a strategic capital raise and new cost-saving measures to fuel growth.

NeuroScientific Biopharmaceuticals has reported promising initial clinical responses from its StemSmart™ Special Access Program treating Fistulising Crohn’s Disease, while preparing for a pivotal Phase 2 trial in 2026.

Lotus Resources reports steady progress at its Kayelekera uranium mine despite supply challenges, while its Letlhakane project shows promising metallurgical advances. The company targets full production and first shipments in the second quarter of 2026.

Fleetwood Limited has appointed Andrea Pidcock as its new CEO, bringing a wealth of operational and commercial leadership experience to the industrial and construction services company. Her appointment signals a strategic push towards operational excellence and growth through modern construction methods.

AdAlta Limited has launched its 'East to West' cellular immunotherapy operations through a strategic collaboration with Shanghai Cell Therapy Group to co-develop BZDS1901, an innovative CAR-T therapy targeting mesothelioma and other solid cancers. The company also strengthened its balance sheet by raising $2.8 million via private placements and repaying key investment agreements.

Fluence Corporation Limited has reported a robust FY 2025 with a 52.3% revenue increase and record new orders, driven by a strategic pivot to higher-margin Smart Product Solutions and recurring revenue streams.